Dr. Jenni Vuola is a Business Development Advisor for Rokote Laboratories Finland Oy. Jenni has a PhD in Microbiology and an Associate Professorship in Infection Research from the University of Helsinki, Finland. She did her post-doc research on malaria vaccine development in Prof. Adrian Hill’s laboratory at Oxford University, UK. Jenni has also obtained a Post Graduate Diploma in Health Economics from the University of York, UK. After her academic research, Jenni worked 20 years in international pharma industry (GSK, SPMSD, and Sanofi), where she held several country and global leadership positions within R&D, market access, and commercial organizations. For the past 2 years Jenni has worked as an independent Consultant/Advisor and a Board Member within the life science space.
13:00 - 'FINVAC: Developing a Universal Intranasal Vaccine Platform' - Jenni Vuola, Buisness Development Advisor, Rokote Laboratories Finland
13:05 - Tom Garnett, CEO & Co-Founder, Refute
13:10 - Damian Alvarez-Paggi, CEO, Eureka Nanobioengineering